Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial
Crossref DOI link: https://doi.org/10.1186/s13018-017-0570-7
Published Online: 2017-05-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Becher, Christoph
Laute, Volker
Fickert, Stefan
Zinser, Wolfgang
Niemeyer, Philipp
John, Thilo
Diehl, Peter
Kolombe, Thomas
Siebold, Rainer
Fay, Jakob
Funding for this research was provided by:
Codon AG (Teltow, Germany)